HOME >> MEDICINE >> NEWS
Accountability in Clinical Research: Balancing Risk and Benefit

INDIANAPOLIS - Human participation in research has surged in recent years as scientists seek causes and cures of myriad diseases. Accompanying the increase too has been greater public concern for patient safety and scrutiny of complex ethical, legal and regulatory issues.

Such issues will be tackled April 24-26 by Indiana University School of Medicine physicians and researchers and other prominent scientists at a national forum at the University Place Conference Center on the Indiana University-Purdue University Indianapolis campus. Accountability in Clinical Research: Balancing Risk and Benefit, sponsored by the National Patient Safety Foundation, will examine the management, conduct, funding and accountability of research involving human subjects.

Sharon M. Moe, M.D., IU School of Medicine's assistant dean for research support, will lead talks in a session about the role of oversight in assuring patient safety in clinical research. Eric M. Meslin, Ph.D., director of the IU Center for Bioethics, takes the lead in discussing the quality and content of information supplied to research patients about their roles and risks Media interest in biomedical research also has sharply increased, often focusing on controversial incidents involving health outcomes of patients. David W. Crabb, M.D., chairman of the School's Department of Medicine, and members of Indianapolis' news media will discuss and analyze real and hypothetical situations and responses to media coverage.

"This conference opens the door to continued dialogue about patient safety issues in clinical research settings," says Carol A. Ley, M.D., Ph.D., chair of NPSF's board of directors.

"The insight and experiences shared at this conference will be invaluable to health-care professionals, researchers, consumers and government entities - all essential in moving patient safety messages to a new level."

Today's health care consumers, payers, providers and profess
'"/>

Contact: Joe Stuteville
jstutevi@iupui.edu
317-274-7722
Indiana University
10-Apr-2002


Page: 1 2

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial participants fare no better, no worse than other patients
4. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
5. National Academies news: Clinical research involving children
6. Clinical research key in advance to prospective health care
7. Clinical trial of new TB vaccine begins
8. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
9. Clinical factors useful to identify heart failure patients with high risk of death
10. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
11. $7 million grant continues Asthma Clinical Research Network efforts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... 2016 , ... A revolution is underway. Brooklyn-based company, ... for the millions of people who require these medical transport services annually. ... the use of technology. Now, SmartEMS has put forth an industry-changing app that ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
Cached News: